Lundstrom, M, et al.
Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology
2007; 114: 866–870.
Al-Mezaine, HS, et al.
Acute-onset nosocomial endophthalmitis after cataract surgery: incidence, clinical features, causative organisms, and visual outcomes. Journal of Cataract and Refractive Surgery
2009; 35: 643–649.
Speaker, MG, et al.
Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology
1991; 98: 639–649.
Kunimoto, DY, et al.
Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Endophthalmitis Research Group. American Journal of Ophthalmology
1999; 128: 240–242.
Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Archives of Ophthalmology
1995; 113: 1479–1496.
Endophthalmitis Vitrectomy Study Group. Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study. American Journal of Ophthalmology
1996; 122: 830–846.
Wu, PC, et al.
Risk of endophthalmitis after cataract surgery using different protocols for povidone iodine preoperative disinfection. Journal of Ocular Pharmacology and Therapeutics
2006; 22: 54–61.
George, JM, et al.
Aqueous and vitreous penetration of linezolid and levofloxacin after oral administration. Journal of Ocular Pharmacology and Therapeutics
2010; 26: 579–586.
O'Brien, TP, Arshinoff, SA, Mah, FS. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin. Journal of Cataract and Refractive Surgery
2007; 33: 1790–1800.
Tan, CS, Wong, HK, Yang, FP. Epidemiology of postoperative endophthalmitis in an Asian population: 11-year incidence and effect of intracameral antibiotic agents. Journal of Cataract and Refractive Surgery
2012; 38: 425–430.
Garat, M, et al.
Prophylactic intracameral cefazolin after cataract surgery: endophthalmitis risk reduction and safety results in a 6-year study. Journal of Cataract and Refractive Surgery
2009; 35: 637–642.
Romero, P, et al.
Intracameral cefazolin as prophylaxis against endophthalmitis in cataract surgery. Journal of Cataract and Refractive Surgery
2006; 32: 438–441.
European Society of Cataract and Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. Journal of Cataract and Refractive Surgery
2007; 33: 978–988.
Gills, JP. Filters and antibiotics in irrigating solution for cataract surgery. Journal of Cataract and Refractive Surgery
1991; 17: 385.
Maldonado, G, Greenland, S. Simulation study of confounder-selection strategies. American Journal of Epidemiology
1993; 138: 923–936.
Ng, JQ, et al.
Reducing the risk for endophthalmitis after cataract surgery: population-based nested case-control study: endophthalmitis population study of Western Australia sixth report. Journal of Cataract and Refractive Surgery
2007; 33: 269–280.
Mamalis, N. Intracameral medication: is it worth the risk?
Journal of Cataract and Refractive Surgery
2008; 34: 339–340.
Olavi, P. Ocular toxicity in cataract surgery because of inaccurate preparation and erroneous use of 50 mg/ml intracameral cefuroxime. Acta Ophthalmologica
2012; 90: 153–154.
Alfonso, EC, Flynn, HW. Jr.
Controversies in endophthalmitis prevention. The risk for emerging resistance to vancomycin. Archives of Ophthalmology
1995; 113: 1369–1370.
Gordon, YJ. Vancomycin prophylaxis and emerging resistance: are ophthalmologist the villains? The heroes?
American Journal of Ophthalmology
2001; 131: 371–3716.
Corner, GM, et al.
Intravitreal daptomycin: a safety and efficacy study. Retina
2011; 31: 1199–1206.
Espiritu, CRG, Caparas, VL, Bolinao, JG. Safety of prophylactic intracameral moxifloxacin 0·5% ophthalmic solution in cataract surgery patients. Journal of Cataract and Refractive Surgery
2007; 33: 63–68.
Ekinci, Koktekir B, Aslan, BS. Safety of prophylactic intracameral moxifloxacin use in cataract surgery. Journal of Ocular Pharmacology and Therapeutics
2012; 28: 278–282.